178 related articles for article (PubMed ID: 27393304)
1. Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.
Saijo S; Nagai A; Kinjo S; Mashimo R; Akimoto M; Kizawa K; Yabe-Wada T; Shimizu N; Takahara H; Unno M
J Mol Biol; 2016 Jul; 428(15):3058-73. PubMed ID: 27393304
[TBL] [Abstract][Full Text] [Related]
2. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
[TBL] [Abstract][Full Text] [Related]
3. Three isozymes of peptidylarginine deiminase in the chicken: molecular cloning, characterization, and tissue distribution.
Shimizu A; Handa K; Honda T; Abe N; Kojima T; Takahara H
Comp Biochem Physiol B Biochem Mol Biol; 2014 Jan; 167():65-73. PubMed ID: 24161753
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type I.
Unno M; Kinjo S; Kizawa K; Takahara H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1357-9. PubMed ID: 24316829
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of human peptidyl-arginine deiminase type III by X-ray crystallography.
Rechiche O; Lee TV; Lott JS
Acta Crystallogr F Struct Biol Commun; 2021 Oct; 77(Pt 10):334-340. PubMed ID: 34605437
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity.
Ranaivoson FM; Bande R; Cardaun I; De Riso A; Gärtner A; Loke P; Reinisch C; Vogirala P; Beaumont E
IUCrJ; 2024 May; 11(Pt 3):395-404. PubMed ID: 38656308
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
8. Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle.
Kizawa K; Takahara H; Troxler H; Kleinert P; Mochida U; Heizmann CW
J Biol Chem; 2008 Feb; 283(8):5004-13. PubMed ID: 18083705
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.
Unno M; Kizawa K; Ishihara M; Takahara H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jun; 68(Pt 6):668-70. PubMed ID: 22684066
[TBL] [Abstract][Full Text] [Related]
10. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
11. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin.
Nachat R; Méchin MC; Takahara H; Chavanas S; Charveron M; Serre G; Simon M
J Invest Dermatol; 2005 Feb; 124(2):384-93. PubMed ID: 15675958
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for Ca(2+)-induced activation of human PAD4.
Arita K; Hashimoto H; Shimizu T; Nakashima K; Yamada M; Sato M
Nat Struct Mol Biol; 2004 Aug; 11(8):777-83. PubMed ID: 15247907
[TBL] [Abstract][Full Text] [Related]
14. Microglial expression of peptidylarginine deiminase 2 in the prenatal rat brain.
Asaga H; Ishigami A
Cell Mol Biol Lett; 2007; 12(4):536-44. PubMed ID: 17579814
[TBL] [Abstract][Full Text] [Related]
15. Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.
Zhao C; Ling B; Dong L; Liu Y
Proteins; 2017 Aug; 85(8):1518-1528. PubMed ID: 28486790
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
18. Peptidylarginine Deiminase and Alzheimer's Disease.
Wang L; Chen H; Tang J; Guo Z; Wang Y
J Alzheimers Dis; 2022; 85(2):473-484. PubMed ID: 34842193
[TBL] [Abstract][Full Text] [Related]
19. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
20. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.
Alghamdi M; Al Ghamdi KA; Khan RH; Uversky VN; Redwan EM
Cell Mol Life Sci; 2019 Dec; 76(23):4635-4662. PubMed ID: 31342121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
